Authors:
AZUMA H
MIMA N
SHIRAKAWA M
MIYAMOTO K
YAMAGUCHI H
MITSUI T
SHIGEKIYO T
SAITO S
Citation: H. Azuma et al., MOLECULAR PATHOGENESIS OF TYPE-I CONGENITAL PLASMINOGEN DEFICIENCY - EXPRESSION OF RECOMBINANT HUMAN MUTANT PLASMINOGENS IN MAMMALIAN-CELLS, Blood, 89(1), 1997, pp. 183-190
Authors:
SHIGEKIYO T
SHIRAKAWA M
KANAZUKA M
MIYAMOTO K
MIMA N
AZUMA H
SAITO S
Citation: T. Shigekiyo et al., EFFECT OF INDOMETHACIN FARNESIL, A PRODRUG OF INDOMETHACIN, ON PLATELET-AGGREGATION IN HUMANS, Clinical drug investigation, 11(2), 1996, pp. 114-116
Citation: N. Mima et al., A NOVEL MISSENSE MUTATION IN 2 FAMILIES WITH CONGENITAL PLASMINOGEN DEFICIENCY - IDENTIFICATION OF AN ALA(675) TO THR(675) SUBSTITUTION, Thrombosis and haemostasis, 75(1), 1996, pp. 96-100
Authors:
AZUMA H
YAMAGUCHI H
MIMA N
SHIRAKAWA M
MIYAMOTO K
KANAGAWA Y
WATANABE A
SHIGEKIYO T
SAITO S
Citation: H. Azuma et al., AN IN-VITRO SYSTEM FOR IDENTIFYING AGENTS CAPABLE OF CHANGING SERUM LIPOPROTEIN(A) CONCENTRATION BY REGULATING THE TRANSCRIPTIONAL ACTIVITYOF THE APOLIPOPROTEIN(A) GENE PROMOTER, Biochemical and biophysical research communications, 227(2), 1996, pp. 570-575
Authors:
AZUMA H
MIMA N
MIYAMOTO K
KONDOH T
TOYOTA K
SHIGEKIYO T
SAITO S
Citation: H. Azuma et al., CONGENITAL PLASMINOGEN DEFICIENCY IN A FAMILY WITH THROMBOSIS CAUSED BY A SER-572 TO PRO MUTATION, Thrombosis and haemostasis, 69(6), 1993, pp. 575-575